newsfilter
← Latest News
PR Newswire·

MetaVia Announces AI-Driven Collaboration with Syntekabio to Explore Additional Indications for DA-1241

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a research...